HCC Prevention Should Target Patients With Moderate Fibrosis HCC Prevention Should Target Patients With Moderate Fibrosis
Efforts to prevent hepatocellular carcinoma unrelated to hepatitis or cirrhosis should be focused on individuals with an intermediate degree of liver fibrosis, suggests a large-scale data analysis.First Look
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Hematology | Hepatitis | Hepatocellular Carcinoma | Liver | Liver Cancer | Urology & Nephrology